Fortrea
CRA II
- Maidenhead
- Mid-level
Monitors clinical trial sites across a diverse portfolio spanning oncology, neuroscience, general medicine, cell & gene and CAR-T therapy. Leads site management, builds relationships with investigators and study teams, and safeguards patient safety and data integrity on complex, first-in-class studies. Distinct for its breadth across therapeutic areas and advanced therapy exposure rather than a narrow single-indication focus.